SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
暂无分享,去创建一个
G. F. Passos | J. Clarke | C. Figueiredo | L. Romão | L. Savio | Talita N. da Silva | A. D. da Poian | A. L. Salvio | K. Pires | F. L. Fontes-Dantas | G. Fernandes | Robson da Costa | Emanuelle V. de Lima | E. G. Gutman | Leticia S. Antonio | M. B. Hammerle | Hannah P. Mota-Araujo | Lilian C. Colodeti | Suzana B. Araújo | Larissa A. Duarte | S. Alves‐Leon | L. A. Leon | Jerson L Silva | Gabrielle M. Froz | C. C. F. Vasconcelos | L. Leon | L. Duarte | F. Fontes-Dantas | H. P. Mota-Araujo | Letícia S. Antônio | Mariana B. Hammerle
[1] C. Granziera,et al. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study , 2022, Nature Communications.
[2] T. Woodruff,et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein , 2022, Molecular Psychiatry.
[3] A. Iwasaki,et al. The neurobiology of long COVID , 2022, Neuron.
[4] V. Kasatkin,et al. The Impact of Mild COVID-19 on Executive Functioning and Mental Health Outcomes in Young Adults , 2022, Healthcare.
[5] Z. Al-Aly,et al. Long-term neurologic outcomes of COVID-19 , 2022, Nature Medicine.
[6] M. Taquet,et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients , 2022, The Lancet Psychiatry.
[7] G. Gkoutos,et al. Symptoms and risk factors for long COVID in non-hospitalized adults , 2022, Nature Medicine.
[8] Lisa E. Gralinski,et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice , 2022, Science Translational Medicine.
[9] J. Switzer,et al. Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA , 2022, Brain, Behavior, & Immunity - Health.
[10] A. Tanuri,et al. From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics , 2022, Biochemical Engineering Journal.
[11] G. Alter,et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae , 2022, medRxiv.
[12] S. Khan,et al. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant , 2022, Virology.
[13] Peter J Hellyer,et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort , 2022, eClinicalMedicine.
[14] Weihong Song,et al. The synapse as a treatment avenue for Alzheimer’s Disease , 2022, Molecular Psychiatry.
[15] B. Haagmans,et al. SARS-CoV-2 pathogenesis , 2022, Nature Reviews Microbiology.
[16] Thomas E. Nichols,et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank , 2022, Nature.
[17] S. Kushner,et al. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2 , 2022, Trends in Neurosciences.
[18] R. Perlis,et al. SARS-CoV-2 promotes microglial synapse elimination in human brain organoids , 2022, bioRxiv.
[19] M. Merad,et al. Pathological sequelae of long-haul COVID , 2022, Nature Immunology.
[20] M. Peluso,et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19 , 2022, Annals of clinical and translational neurology.
[21] Jinpyo Hong,et al. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death , 2022, Scientific Reports.
[22] Nelson B Rodrigues,et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis , 2021, Brain, Behavior, and Immunity.
[23] S. Maier,et al. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties , 2021, Brain, Behavior, and Immunity.
[24] Tony Y. Hu,et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates , 2020, Nature Communications.
[25] Benjamin J. Polacco,et al. Evolution of enhanced innate immune evasion by SARS-CoV-2 , 2021, Nature.
[26] Suji Kim,et al. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells , 2021, Viruses.
[27] Arvid Edén,et al. Author Response: CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series , 2021, Neurology.
[28] P. Edison,et al. Long covid—mechanisms, risk factors, and management , 2021, BMJ.
[29] P. Xie,et al. BoDV‐1 infection induces neuroinflammation by activating the TLR4/MyD88/IRF5 signaling pathway, leading to learning and memory impairment in rats , 2021, Journal of medical virology.
[30] V. Felipo,et al. A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease , 2021, Journal of clinical medicine.
[31] H. Bartsch,et al. Long COVID in a prospective cohort of home-isolated patients , 2021, Nature Medicine.
[32] I. Cobos,et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19 , 2021, Nature.
[33] M. Hallek,et al. Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 , 2021, EMBO molecular medicine.
[34] L. Petrucelli,et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19 , 2021, Science Translational Medicine.
[35] Kenneth A. Matreyek,et al. Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies , 2021, Journal of extracellular vesicles.
[36] M. Filippi,et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients , 2021, Journal of Neurology.
[37] T. Cokelaer,et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters , 2021, Science Translational Medicine.
[38] K. Blennow,et al. Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness , 2021, medRxiv.
[39] C. V. von Bartheld,et al. Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19 , 2021, bioRxiv.
[40] A. Banerjee,et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study , 2021, BMJ.
[41] C. Taylor,et al. Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” , 2021, Annals of clinical and translational neurology.
[42] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[43] Xiangxi Wang,et al. SARS-CoV-2 spike protein interacts with and activates TLR41 , 2021, Cell Research.
[44] M. Peluso,et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients , 2021, Journal of NeuroVirology.
[45] M. Peluso,et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations , 2021, Cells.
[46] T. Kizaki,et al. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages , 2021, Heliyon.
[47] M. Peluso,et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients , 2021, Journal of neurovirology.
[48] D. Raoult,et al. 18F-FDG brain PET hypometabolism in patients with long COVID , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[49] R. Heads,et al. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation , 2021, Mediators of inflammation.
[50] M. Prinz,et al. The roles of microglia in viral encephalitis: from sensome to therapeutic targeting , 2021, Cellular & Molecular Immunology.
[51] H. Zetterberg,et al. SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] O. Olajide,et al. SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia , 2020, bioRxiv.
[53] G. Nuovo,et al. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein , 2020, Annals of Diagnostic Pathology.
[54] G. Fabbrocini,et al. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19 , 2020, Diagnostic Pathology.
[55] Ryan J. Low,et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2020, EClinicalMedicine.
[56] W. Banks,et al. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice , 2020, Nature Neuroscience.
[57] C. Conrad,et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 , 2020, Nature Neuroscience.
[58] A. Tenner,et al. The good, the bad, and the opportunities of the complement system in neurodegenerative disease , 2020, Journal of Neuroinflammation.
[59] A. Tenner,et al. The good, the bad, and the opportunities of the complement system in neurodegenerative disease , 2020, Journal of neuroinflammation.
[60] Ashish Ranjan Sharma,et al. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex , 2020, Infection, Genetics and Evolution.
[61] M. Aepfelbacher,et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.
[62] C. Ko,et al. Discordant anti‐SARS‐CoV‐2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein , 2020, Journal of cutaneous pathology.
[63] Chu-Chung Huang,et al. Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up Study , 2020, EClinicalMedicine.
[64] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[65] S. Farhadian,et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.
[66] K. Blennow,et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19 , 2020, Neurology.
[67] Xianwei Wang,et al. Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer’s Disease , 2020, Frontiers in Neuroscience.
[68] A. Benachi,et al. Transplacental transmission of SARS-CoV-2 infection , 2020, Nature Communications.
[69] S. Mukherjee,et al. In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs , 2020, Journal of medical virology.
[70] K. Fukuchi,et al. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease , 2020, Frontiers in Immunology.
[71] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[72] M. Navarrete,et al. TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury , 2020, bioRxiv.
[73] L. Schneider,et al. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease , 2020, Alzheimer's Research & Therapy.
[74] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[75] Zongze Zhang,et al. Toll-like receptor 4 deficiency ameliorates β2-microglobulin induced age-related cognition decline due to neuroinflammation in mice , 2020, Molecular Brain.
[76] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[77] wei zhang,et al. The Immune System Drives Synapse Loss During Lipopolysaccharide-Induced Learning and Memory Impairment in Mice , 2019, Front. Aging Neurosci..
[78] S. Ferreira,et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice , 2019, Nature Communications.
[79] A. Semlali,et al. Toll‐like receptor 4 polymorphisms in Saudi population with cardiovascular diseases , 2019, Molecular genetics & genomic medicine.
[80] J. Poirier,et al. Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation , 2019, Alzheimer's & Dementia.
[81] K. Blennow,et al. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. , 2019, JAMA neurology.
[82] Zhuangzhuang Chen,et al. The role of microglia in viral encephalitis: a review , 2019, Journal of neuroinflammation.
[83] E. Greenfield. Sampling and Preparation of Mouse and Rat Serum. , 2017, Cold Spring Harbor protocols.
[84] K. Tyler,et al. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis , 2017, Journal of Neuroimmunology.
[85] G. Tononi,et al. Sleep Loss Promotes Astrocytic Phagocytosis and Microglial Activation in Mouse Cerebral Cortex , 2017, The Journal of Neuroscience.
[86] John D Lambris,et al. More than complementing Tolls: complement–Toll‐like receptor synergy and crosstalk in innate immunity and inflammation , 2016, Immunological reviews.
[87] Robert E. Schmidt,et al. A complement–microglial axis drives synapse loss during virus-induced memory impairment , 2016, Nature.
[88] Ben A. Barres,et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.
[89] Veeranna,et al. Neurofilament Subunits are Integral Components of Synapses and Modulate Neurotransmission and Behavior In Vivo , 2015, Molecular Psychiatry.
[90] Ping Liu,et al. Correlation of Hippocampal Volume and Cognitive Performances in Patients with Either Mild Cognitive Impairment or Alzheimer's disease , 2015, CNS neuroscience & therapeutics.
[91] D. Finn,et al. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice. , 2015, Cerebral cortex.
[92] Tyrone D. Cannon,et al. Maternal complement C1q and increased odds for psychosis in adult offspring , 2014, Schizophrenia Research.
[93] Koanhoi Kim,et al. Distinct Dictation of Japanese Encephalitis Virus-Induced Neuroinflammation and Lethality via Triggering TLR3 and TLR4 Signal Pathways , 2014, PLoS pathogens.
[94] Taro Kawai,et al. Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..
[95] N. Sarvetnick,et al. TLR signaling controls lethal encephalitis in WNV-infected brain , 2014, Brain Research.
[96] N. Agrawal,et al. Toll-like receptor 4 polymorphisms and their haplotypes modulate the risk of developing diabetic retinopathy in type 2 diabetes patients , 2014, Molecular vision.
[97] G. Malerba,et al. Polymorphism −2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients , 2013, Journal of Human Genetics.
[98] Yen-Ching Chen,et al. Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease , 2012, PloS one.
[99] R. Panizzutti,et al. Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth Factor β Signaling through Modulation of d-Serine Levels in Cerebral Cortex Neurons* , 2012, The Journal of Biological Chemistry.
[100] Ben A. Barres,et al. Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.
[101] Jin-Tai Yu,et al. Common variants in toll-like receptor 4 confer susceptibility to Alzheimer's disease in a Han Chinese population. , 2012, Current Alzheimer research.
[102] L. Tan,et al. Genetic association of TLR4/11367 polymorphism with late-onset Alzheimer's disease in a Han Chinese population , 2011, Brain Research.
[103] D. Postma,et al. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma , 2010, Thorax.
[104] Anders M. Fjell,et al. Hippocampal volumes are important predictors for memory function in elderly women , 2009, BMC Medical Imaging.
[105] Choung-Soo Kim,et al. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. , 2009, Cancer genetics and cytogenetics.
[106] Sung-Chun Tang,et al. Toll-like receptors in neurodegeneration , 2009, Brain Research Reviews.
[107] S. Santi,et al. Hippocampal hypometabolism predicts cognitive decline from normal aging , 2008, Neurobiology of Aging.
[108] John D. Lambris,et al. The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.
[109] A. Garenne,et al. Borna Disease Virus Infection Impairs Synaptic Plasticity , 2007, Journal of Virology.
[110] E. Ling,et al. Microglial activation and its implications in the brain diseases. , 2007, Current medicinal chemistry.
[111] C. Vorhees,et al. Morris water maze: procedures for assessing spatial and related forms of learning and memory , 2006, Nature Protocols.
[112] G. Almazan,et al. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice , 2006, Virology.
[113] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[114] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[115] F. Schaffner,et al. Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.